Hospice Care — Compassionate End-of-Life Support

Hospice care is an integrated model of palliative medicine dedicated to the end-stage phase of disease, typically when an individual's life expectancy is estimated at six months or less. It shifts the primary focus of medical management from disease-directed, curative interventions to intensive symptom palliation, psychological support, and functional comfort.

Delivered by an interdisciplinary team comprising palliative physicians, specialised nurses, social workers, spiritual counsellors, and trained volunteers, hospice addresses the physical, emotional, and existential distress associated with dying. Care can be provided across diverse settings—including private residences, dedicated hospice facilities, care homes, or acute hospital units—ensuring patient autonomy and comfort remain central throughout the final months of life.

Entering hospice care enables patients to maintain control over their medical decisions and physical comfort during their final chapter. It prevents unnecessary emergency department visits, invasive procedures, and prolonged hospitalisations that may not align with personal goals. By addressing pain and distress comprehensively, hospice allows patients to achieve peaceful closure, supports family caregivers through exhausting caregiving demands, and provides bereavement resources that extend well beyond the patient's passing.

Hospice care does not involve diagnostic biomarkers or staging biopsies. Instead, eligibility is evaluated through clinical assessments of functional decline, using validated metrics like the Palliative Performance Scale (PPS) or the Eastern Cooperative Oncology Group (ECOG) performance score. Physicians evaluate nutritional failure, progressive organ dysfunction, and persistent weight loss to estimate prognosis and establish appropriate care goals.

Hospice care applies to any advanced malignancy when disease-directed therapies have been exhausted or are declined by the patient. It is frequently utilised in advanced solid tumours, such as lung, pancreatic, colorectal, and breast cancers, as well as aggressive haematological malignancies like relapsed acute leukaemias or lymphomas where therapeutic options can no longer halt disease progression.

Treatment within hospice focuses strictly on symptom control rather than disease eradication. Pharmacotherapy emphasises strong analgesics such as opioids for pain, antiemetics for nausea, anxiolytics for agitation, and anticholinergic agents for respiratory secretions. Interventions like palliative radiotherapy or paracentesis may occasionally be used if their sole purpose is relieving intractable discomfort or pressure.